J. Poo

J. Pedraza-Chaverri, A. Panduro, J. Armendáriz-Borunda, 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.

J. Pedraza-Chaverri, M. Uribe, J. Poo, 1995, Renal failure.

Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders.

D. Kershenobich, M. Uribe, J. Poo, 2008, Annals of hepatology.

Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.

G. Feldmann, C. Gaudin, D. Lebrec, 1992, Gastroenterology.

Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: frequency and clinical manifestations.

M. Uribe, J. Lizardi-Cervera, J. Poo, 2005, Annals of hepatology.

Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency.

O. Mutchinick, S. Bassol, A. Ulloa-Aguirre, 1985, The Journal of clinical endocrinology and metabolism.

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

M. Silva, D. Cutler, M. Grace, 2006, Journal of hepatology.

Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.

M. Uribe, N. Méndez-Sánchez, S. Morán, 1998, Scandinavian journal of gastroenterology.

Triple combination of thymalfasin, peginterferon alfa‐2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24‐week interim results of a pilot study

D. Kershenobich, F. Sánchez-Ávila, J. Poo, 2004, Journal of gastroenterology and hepatology.

Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure.

M. Uribe, S. Morán, J. Poo, 2007, World journal of gastroenterology.

Hepatic hematoma and hepatic rupture in pregnancy.

J. Poo, J. Góngora, 2006, Annals of hepatology.

THE CHALLENGE AND COMPLEXITY OF FOCUSING ON OUTCOMES VERSUS SAMPLE SIZE IN DIABETIC FOOT ULCER RESEACH

G. Tapia, J. Poo, 2020 .

Etiology of liver cirrhosis in Mexico.

M. Uribe, J. Aguirre, N. Méndez-Sánchez, 2004, Annals of hepatology.

Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.

J. Poo, J. Galán-Herrera, Victoria Burke-Fraga, 2009, Clinical therapeutics.

Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City.

M. Uribe, H. Bourges, J. Poo, 1995, Digestive diseases.

Usefulness of cryohemolysis test in the diagnosis of hereditary spherocytosis.

R. R. Romero, A. Majluf-Cruz, J. Poo, 1997, Archives of medical research.

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.

J. Masferrer, W. Jiménez, V. Arroyo, 1999, Gastroenterology.

Challenges in treating liver fibrosis.

J. Poo, L. Muñoz, 2014, Annals of hepatology.

Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity

J. Lang, G. Dayan, B. Zambrano, 2011, The Pediatric infectious disease journal.

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

M. Uribe, L. Rodríguez-Fragoso, F. Sánchez-Ávila, 2006, Annals of hepatology.

Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial

G. García-García, J. Armendáriz-Borunda, L. García-Benavides, 2021, International journal of nephrology.

Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.

J. Poo, José Alfonso Maya-Barrios, J. Galán-Herrera, 2008, Clinical therapeutics.

[81] EFFICACY AND SAFETY OF L-ORNITHINE-L-ASPARTATE (LOLA) ADMINISTRATION. OPEN LABEL RANDOMIZED CONTROLLED TRIAL VERSUS LACTULOSE IN CIRRHOTIC PATIENTS WITH HYPERAMMONEMIC HEPATIC ENCEPHALOPATHY

M. Uribe, J. F. Sánchez-Ávila, L. Rodríguez-Fragoso, 2007 .

Diagnostic value of the copper/zinc ratio in digestive cancer: a case control study.

R. R. Romero, M. Uribe, J. Poo, 1997, Archives of medical research.

Hemodynamic effects of terbutaline, a β2‐adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis

C. Gaudin, D. Lebrec, A. Braillon, 1992, Hepatology.

Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

A. Rosete, J. Poo, Victoria Burke-Fraga, 2008, Clinical therapeutics.

In Vitro and In Vivo Lactose and Lactulose Effects on Colonic Fermentation and Portal-systemic Encephalopathy Parameters.

J. Poo, S. Morán V, M. Uribe-Esquivel, 1997, Scandinavian journal of gastroenterology.

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

E. Schiff, J. Bruix, J. Albrecht, 2011, Gastroenterology.

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

M. Silva, D. Cutler, M. Grace, 2006, Journal of hepatology.

Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.

W. Jiménez, M. Morales-Ruiz, V. Arroyo, 1999, Gastroenterology.